Rimonabant, a Selective Cannabinoid CB1 Receptor Antagonist, Inhibits Atherosclerosis in LDL Receptor–Deficient MiceFrédérique Dol-Gleizes, Françoise Bono, Virgile Visentin et al.|Arteriosclerosis Thrombosis and Vascular Biology|2008Cited by 124